Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application. - Wikidata - wikimedia - TriplyDB

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

http://www.wikidata.org/entity/Q34687048

about

Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.Pharmacokinetics of quinolones: newer aspects.Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers.Intrinsic enantioselectivity of natural polynucleotides modulated by copper ions.Influence of co-administered antibiotics on the pharmacokinetic fate in rats of paeoniflorin and its active metabolite paeonimetabolin-I from Shaoyao-Gancao-tang.Repetitive administration of Shaoyao-Gancao-tang to rats restores the bioavailability of glycyrrhizin reduced by antibiotic treatment.Open tubular layer of S-ofloxacin imprinted polymer fabricated in silica capillary for chiral CEC separation.Chiral discrimination of ofloxacin enantiomers using DNA double helix regulated by metal ions.Multiple Response Optimization of a HPLC Method for the Determination of Enantiomeric Purity of S-Ofloxacin

P2860

Q35307603-8A729DEE-A5CA-404D-8D76-B9ABBBAF8FE3 Q35353352-BBD76039-9639-4896-9FB6-99A19E25192D Q37222580-B1709AC1-E2B3-4B5C-8302-51C90110EE69 Q40085961-3993253F-BF66-4DB3-A381-4E247676A1CF Q41459498-43333667-D6C7-4B60-9D13-14E7E152A007 Q44424893-71B390A8-103B-42DE-A7C6-D0B7B68375CC Q44720813-B4AB1071-3895-4FD1-8D55-F89088F81F03 Q46097864-5FB0707F-4C38-42D8-9A5B-9FB70D95E317 Q50462044-92845388-DD44-405C-8EE3-B96EFC70DC7F Q56336465-EFE43066-B6B2-45DA-86E6-1DF11A497025

P2860

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

http://www.wikidata.org/entity/Q34687048

description

1988 nî lūn-bûn

@nan

1988 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@ast

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@en

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@nl

type

label

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@ast

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@en

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@nl

prefLabel

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@ast

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@en

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@nl

P1433

Q34687048-9F71BCCD-2921-4B82-AD0C-73E4E0FAE32D

P1476

Q34687048-9D35D551-9E73-4234-9A20-65A3DE7032F2

P2093

Q34687048-67B7A0D6-A392-4BC3-A65C-0DAC97B72ECC

Q34687048-997624CF-A7C9-4BD4-AD4B-19C760C6E6EB

P2860

Q34687048-052505AB-6BBF-40E9-A603-F8D2A8C3B34B

Q34687048-05890948-0B0E-46FC-84B3-E72B0EDEAA01

Q34687048-1382DB76-A396-4BAA-9B23-68872ACB5990

Q34687048-13CFF3B4-37B0-4C2C-A80C-2A916778AF6F

Q34687048-1794D456-C810-4C29-926F-ABE9F367E82F

Q34687048-21C5EA86-C439-4C35-ADAC-2324D412F5B5

Q34687048-221B3D4A-63EB-483D-9A50-0BA9106F94FB

Q34687048-22DFE670-36D5-424B-8CAD-E51791964DD9

Q34687048-28780161-4446-4610-A112-96355BD0CB20

Q34687048-29BEF797-8DD9-499F-B0AA-B3847C4F732E

P304

Q34687048-06288EF7-5019-442B-9F52-ECEFE9D4A408

P31

Q34687048-695A03A7-1D6A-4F36-9272-77DF7860E00A

P356

Q34687048-99053C3B-39AC-4A78-8AB0-6A839AEB9786

P407

Q34687048-4AAA59F4-F774-46D7-9626-D8E55E7268A1

P433

Q34687048-8F9443BE-8AAF-4CFF-9C0A-999FF6A596CD

P478

Q34687048-BAFF4B2F-A146-4EAC-A02D-C116D3CB1881

P577

Q34687048-CA9AD8D0-6F93-48EC-A4C1-628D747BCFA1

P698

Q34687048-36B36ED2-305E-4A9E-8703-1DD5755D9879

P921

Q34687048-39BE1B4C-6239-41EA-8EC1-321C496788B3

P356

J.1875-9114.1988.TB04063.X

P1433

Pharmacotherapy

P1476

Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.

@en

P2093

Drew RH

http://www.w3.org/2001/XMLSchema#string

Gallis HA

http://www.w3.org/2001/XMLSchema#string

P2860

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

In vitro and in vivo activity of DL-8280, a new oxazine derivative

In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone

In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents

Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.

Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.

Activities of new quinoline derivatives against genital pathogens.

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence

P304

35-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/J.1875-9114.1988.TB04063.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

1988-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3287354

http://www.w3.org/2001/XMLSchema#string

P921